The chief of drugmaker Eli Lilly & Co.  said Wednesday that he expects the bulk of this year’s  U.S. health care overhaul to remain intact despite Tuesday’s election victories by anti-overhaul Republicans.

But with Republicans taking control of the House of Representatives from the Democrats, Chief Executive John Lechleiter said he will lobby to overturn at least one provision of the overhaul: the creation of an independent payment advisory board tasked with controlling growth in spending by  Medicare. Get the full story »